Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
KCNQ4 encodes the voltage-gated potassium channel Kv7.4, critical for outer hair cell repolarization in the cochlea. Heterozygous loss-of-function variants of KCNQ4 underlie DFNA2A, a progressive, high-frequency sensorineural hearing loss. Since the initial identification of KCNQ4 in autosomal dominant hearing loss, multiple independent studies across diverse populations have confirmed its pathogenic role.
Autosomal dominant inheritance is well established for KCNQ4-related hearing loss. Recurrent heterozygous c.140T>C (p.Leu47Pro) segregates in four Korean families ([PMID:30556268]) and a semi-dominant p.Pro291Leu variant segregates in two affected individuals of a consanguineous kindred ([PMID:31028865]). An exome screen of 9 probands uncovered seven additional missense and one frameshift variant in patients with adult-onset hearing loss ([PMID:37009795]). Collectively, these studies include 15 probands ([PMID:37009795]), segregation in 6 families ([PMID:30556268]; [PMID:31028865]), and concordant functional data ([PMID:18030493]).
Pathogenic variants cluster in the pore region and proximal C-terminus, including c.886G>A (p.Gly296Ser) ([PMID:18030493]), c.808T>C (p.Tyr270His) ([PMID:22420747]), and c.796G>T (p.Asp266Tyr) ([PMID:30413759]). The founder p.Leu47Pro mutation recurs in multiple Korean kindreds, and numerous private missense and small deletion variants have been reported worldwide. Segregation analysis demonstrates cosegregation with hearing loss in at least 6 families, confirming dominant inheritance.
In vitro patch-clamp assays reveal that pore-region mutants (p.Gly296Ser, p.Gly321Ser) abolish K+ currents and exert dominant-negative inhibition of wild-type channels ([PMID:23750663]; [PMID:18030493]). The proximal C-terminus mutation p.Gly321Ser also impairs surface expression, rescued by HSP90β overexpression ([PMID:23750663]; [PMID:23431407]). Synthetic channel openers such as retigabine and zinc pyrithione restore function in certain C-terminal mutants ([PMID:21951272]). Alternative splicing and KCNE β-subunit coassembly modulate channel gating and trafficking, supporting both haploinsufficiency and dominant-negative mechanisms ([PMID:17561493]; [PMID:16914890]).
The convergence of robust segregation in multiple families, a spectrum of missense and truncating variants, and concordant electrophysiological and expression data supports a Strong clinical validity for KCNQ4 in autosomal dominant nonsyndromic hearing loss. Genetic testing for KCNQ4 variants enables precise diagnosis, anticipatory guidance, and therapeutic avenues—particularly where channel openers can rescue residual function. Key take-home: KCNQ4 screening is essential for early identification of treatable DFNA2A cases and delivery of genotype-tailored interventions.
Gene–Disease AssociationStrong15 probands ([PMID:37009795]), segregation in 6 families ([PMID:30556268]; [PMID:31028865]), concordant functional data ([PMID:18030493]) Genetic EvidenceStrongRecurrent c.140T>C (p.Leu47Pro) in 4 Korean families ([PMID:30556268]), p.Pro291Leu segregates semi-dominantly ([PMID:31028865]), 9 additional probands with rare variants ([PMID:37009795]), AD inheritance Functional EvidenceModeratePatch-clamp shows LOF for p.Gly296Ser and p.Gly321Ser ([PMID:23750663]); rescue by retigabine/zinc pyrithione ([PMID:21951272]); impaired surface expression and dominant-negative effects ([PMID:18030493]) |